TGFB2 and metabolic dysfunction-associated steatohepatitis: Therefore, our results suggest that the DHA attenuation of BTC‐TGFβ‐2‐dependent molecular events might not be limited to reversal of fibrosis in NASH (Lytle et al, 2015) but also has a promise in preventing NASH's progression into liver cancer.